Major Milestone: Myoin Society Receives Section 12A Income Tax Exemption
We are delighted to announce that Myoin Society has been granted provisional registration under Section 12A of the Income Tax Act, 1961, on October 21, 2025. This significant achievement marks another crucial step in our journey toward advancing myositis research and patient care in India.Myoin-12A-Certificate.pdf
Our 12A Registration Details:
- Registration Date: October 21, 2025Myoin-12A-Certificate.pdf
- Unique Registration Number: AAOAM2491GE20251Myoin-12A-Certificate.pdf
- Document ID: AAOAM2491GE2025101Myoin-12A-Certificate.pdf
- Validity: Assessment Years 2026-27 to 2028-29 (3 years)Myoin-12A-Certificate.pdf
- PAN: AAOAM2491GMyoin-12A-Certificate.pdf
What This Achievement Means:
Tax Exemption Benefits: With Section 12A registration, Myoin Society is now exempt from paying income tax on surplus income derived from our charitable activities. This means every rupee donated can be channeled directly toward myositis research, patient support, and healthcare initiatives without tax deductions.
Enhanced Credibility: The 12A certificate serves as official government recognition of our genuine charitable work, significantly boosting our credibility with donors, research partners, and collaborating institutions.
Our Commitment:
This provisional registration comes with strict compliance requirements to ensure genuine charitable activities. We are committed to maintaining separate books of account, transparent operations, and using all funds exclusively for our stated objectives of advancing myositis research and patient care.Myoin-12A-Certificate.pdf
Looking Forward:
As we operate under this 3-year provisional period (AY 2026-27 to 2028-29), we will work diligently to convert this to permanent registration by demonstrating consistent charitable activities and compliance with all regulatory requirements.Myoin-12A-Certificate.pdf
This milestone, combined with our recent DARPAN registration (TS/2025/0799367), positions Myoin Society as a fully compliant, government-recognized organization ready to make an even greater impact in the fight against myositis.Darpan-Registration-Doc.pdf
We thank all our supporters, donors, and collaborators who have made this achievement possible. With these regulatory milestones complete, we can focus our full energy on our core mission: improving lives through myositis research and patient care.
